Insights

Strategic Partnerships Target collaborations with academic medical centers and HTAN programs leveraging the G4X Spatial Sequencer for tumor atlas initiatives, expanding reference datasets and clinical adoption.

Clinical Translation Position G4X as enabling translational research from population-scale spatial omics to precision diagnostics, aligning with potential customers pursuing translational medicine and biomarker discovery.

Custom Kit Opportunities Leverage announced collaboration on customized NGS reagent kits to offer co-developed workflows, integration services, and bundled solutions for library preparation and spatial multiomics.

Regional Leadership Highlight recent executive appointment and leadership continuity to reassure buyers about strategic focus, customer support, and long‑term roadmap in high-throughput spatial analytics.

Security & Compliance Proactively address data governance and breach concerns by offering robust security features, compliance messaging, and clear incident response commitments to prospective customers with sensitive data.

Singular Genomics Tech Stack

Singular Genomics uses 8 technology products and services including Linkedin Insight Tag, Cloudflare CDN, Snowflake, and more. Explore Singular Genomics's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • Snowflake
    Data Management Platforms
  • Stateflow
    Dev Tools
  • Kinsta
    Platform As A Service
  • Python
    Programming Languages
  • Smartsheet
    Project Management
  • Google Tag Manager
    Tag Management

Media & News

Singular Genomics's Email Address Formats

Singular Genomics uses at least 1 format(s):
Singular Genomics Email FormatsExamplePercentage
FirstL@singulargenomics.comJohnD@singulargenomics.com
56%
FLast@singulargenomics.comJDoe@singulargenomics.com
25%
First@singulargenomics.comJohn@singulargenomics.com
10%
Last@singulargenomics.comDoe@singulargenomics.com
9%

Frequently Asked Questions

What is Singular Genomics's stock symbol?

Minus sign iconPlus sign icon
Singular Genomics is a publicly traded company; the company's stock symbol is OMIC.

What is Singular Genomics's official website and social media links?

Minus sign iconPlus sign icon
Singular Genomics's official website is singulargenomics.com and has social profiles on LinkedInCrunchbase.

What is Singular Genomics's SIC code NAICS code?

Minus sign iconPlus sign icon
Singular Genomics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Singular Genomics have currently?

Minus sign iconPlus sign icon
As of July 2026, Singular Genomics has approximately 162 employees across 3 continents, including North AmericaAsiaSouth America. Key team members include Head Of Human Resources: V. B.Vp. Engineering: B. J. C.Vice President, Sequencing Applications: M. F.. Explore Singular Genomics's employee directory with LeadIQ.

What industry does Singular Genomics belong to?

Minus sign iconPlus sign icon
Singular Genomics operates in the Biotechnology Research industry.

What technology does Singular Genomics use?

Minus sign iconPlus sign icon
Singular Genomics's tech stack includes Linkedin Insight TagCloudflare CDNSnowflakeStateflowKinstaPythonSmartsheetGoogle Tag Manager.

What is Singular Genomics's email format?

Minus sign iconPlus sign icon
Singular Genomics's email format typically follows the pattern of FirstL@singulargenomics.com. Find more Singular Genomics email formats with LeadIQ.

How much funding has Singular Genomics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Singular Genomics has raised $176M in funding. The last funding round occurred on May 12, 2021 for $131M.

When was Singular Genomics founded?

Minus sign iconPlus sign icon
Singular Genomics was founded in 2016.
Singular Genomics logo

Singular Genomics

Biotechnology ResearchCalifornia, United States51-200 Employees

Singular Genomics is a biotechnology research company located in San Diego, California, with a workforce of about 51 to 200 employees. It develops spatial pathology technologies, most notably the G4X Platform, described as a high-throughput in situ multiomics system intended to advance precision diagnostics and personalized medicine. In 2026 the company launched G4X in the United States and established collaborations, including with Vanderbilt University Medical Center to support the HTAN Pre-Gastric Cancer program and with Tecan Group AG to develop customized reagent kits for NGS library preparation. John Stark was named Chief Executive Officer in April 2026, as the company continues to build on momentum around its spatial platform. Financial disclosures indicate revenue in the tens of millions and total funding around $131 million.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
OMIC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $176M

    Singular Genomics has raised a total of $176M of funding over 4 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $131Mas a convertible_note.

  • $50M$100M

    Singular Genomics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $176M

    Singular Genomics has raised a total of $176M of funding over 4 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $131Mas a convertible_note.

  • $50M$100M

    Singular Genomics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.